Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. (EIGR) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 104 transactions totaling $7.8M, demonstrating a bullish sentiment with $1.6M in net insider flow. The most recent transaction on Nov 2, 2023 involved a purchase of 23,398 shares valued at $7.0K.
EIGR Insider Activity Summary
Who Is Buying EIGR Stock?
No significant insider buying has been recorded for EIGR in the recent period.
Who Is Selling EIGR Stock?
No significant insider selling has been recorded for EIGR in the recent period.
Is Eiger BioPharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EIGR is bullish with an Insider Alignment Score of 61/100 and a net flow of $1.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
EIGR Frequently Asked Questions
Understanding EIGR Insider Activity
Insider trading at Eiger BioPharmaceuticals, Inc. (EIGR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading EIGR stock, having executed 104 transactions in the past 90 days. The most active insider is Ventures Fund Vi, L.p. Vivo (Executive), who has made 2 transactions totaling $3.0M.
Related Tools
Track Eiger BioPharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at EIGR file new Form 4 transactions